Pagano Rosana L, Dias Maria Angela Amorim, Dale Camila S, Giorgi Renata
Laboratory of Pathophysiology, Butantan Institute, Av Vital Brazil 1500, São Paulo, 05503-900 São Paulo, SP, Brazil.
Mediators Inflamm. 2002 Aug;11(4):203-10. doi: 10.1080/0962935029000050.
We have previously shown that the calcium-binding protein MRP-14 secreted by neutrophils mediates the antinociceptive response in an acute inflammatory model induced by the intraperitoneal injection of glycogen in mice.
In an attempt to broaden the concept that neutrophils and MRP-14 controls inflammatory pain induced by different type of irritants, in the present study, after demonstrating that carrageenan (Cg) also induces atinociception in mice, we investigated the participation of both neutrophils and MRP-14 in the phenomenon.
Male Swiss mice were injected intraperitoneally with Cg and after different time intervals, the pattern of cell migration of the peritoneal exudate and the nociceptive response of animals submitted to the writhing test were evaluated. The participation of neutrophils and of the MRP-14 on the Cg effect was evaluated by systemic inoculation of monoclonal antibodies anti-granulocyte and anti-MRP-14.
Our results demonstrate that the acute neutrophilic peritonitis evoked by Cg induced antinociception 2, 4 and 8 h after inoculation of the irritant. Monoclonal antibodies anti-granulocyte or anti-MRP-14 reverts the antinociceptive response only 2 and 8 h after Cg injection. The antibody anti-MRP-14 partially reverts the antinociception observed after 4 h of Cg injection while the anti-granulocyte antibody enhances this effect. This effect is reverted by simultaneous treatment of the animals with both antibodies. After 4 h of Cg injection in neutrophil-depleted mice a significant expression of the calcium-binding protein MRP-14 was detected in the cytoplasm of peritoneal macrophages. This suggests that the enhancement of the effect observed after treatment with the anti-neutrophil antibody may be due to secretion of MRP-14 by macrophages. It has also been demonstrated that endogenous opioids and glucocorticoids are not involved in the antinociception observed at the 4th hour after Cg injection.
These data support the hypothesis that neutrophils and the calcium-binding protein MRP-14 are participants of the endogenous control of inflammatory pain in mice despite the model of acute inflammation used.
我们之前已经表明,中性粒细胞分泌的钙结合蛋白MRP-14在小鼠腹腔注射糖原诱导的急性炎症模型中介导抗伤害感受反应。
为了拓宽中性粒细胞和MRP-14控制由不同类型刺激物诱导的炎性疼痛这一概念,在本研究中,在证实角叉菜胶(Cg)也能诱导小鼠产生抗伤害感受后,我们研究了中性粒细胞和MRP-14在该现象中的作用。
给雄性瑞士小鼠腹腔注射Cg,在不同时间间隔后,评估腹腔渗出液的细胞迁移模式以及接受扭体试验的动物的伤害感受反应。通过全身接种抗粒细胞单克隆抗体和抗MRP-14单克隆抗体来评估中性粒细胞和MRP-14对Cg效应的作用。
我们的结果表明,Cg诱发的急性嗜中性粒细胞性腹膜炎在注射刺激物后2、4和8小时诱导了抗伤害感受。抗粒细胞或抗MRP-14单克隆抗体仅在Cg注射后2和8小时逆转抗伤害感受反应。抗MRP-14抗体部分逆转了Cg注射4小时后观察到的抗伤害感受,而抗粒细胞抗体增强了这种效应。同时用两种抗体治疗动物可逆转这种效应。在中性粒细胞减少的小鼠中注射Cg 4小时后,在腹腔巨噬细胞的细胞质中检测到钙结合蛋白MRP-14的显著表达。这表明用抗中性粒细胞抗体治疗后观察到的效应增强可能是由于巨噬细胞分泌MRP-14。还已证明内源性阿片类物质和糖皮质激素不参与Cg注射后第4小时观察到的抗伤害感受。
这些数据支持以下假设,即尽管使用了急性炎症模型,但中性粒细胞和钙结合蛋白MRP-14是小鼠炎性疼痛内源性控制的参与者。